Micah Onixt

Mr. Onixt is currently General Counsel and a Managing Director of LTR. Through LTR, he brings to C₂N over 20 years of life sciences work experience. He was part of the team that helped to form C₂N and to transfer the SILK-related intellectual property out of WU. He also was a partner in the Chicago office of the law firm of DLA LLP US and a recipient of the “40 Illinois Attorneys Under 40 to Watch” award from the Law Bulletin Publishing Company. During his 12 year tenure at DLA Piper, his practice consisted of representing both institutional investment funds, and private and public life sciences companies in the areas of corporate securities, technology transfer (product licensing, M&A), and intellectual property management. He has negotiated many partnerships; and drafted and prosecuted patents, copyrights, and trade secrets within the biotechnology, pharmaceutical and medical device spaces. Mr. Onixt received his MBA from the Northwestern University Kellogg School of Management in 2007, JD from Loyola University in 1998, a MS in Biology from the Illinois Institute of Technology in 2017, and two bachelor’s degrees from the University of Michigan (English, ‘94) and University of Illinois at Chicago (Cellular Biology, ‘95).